CS258203B1 - Method of animal albumin insulation - Google Patents

Method of animal albumin insulation Download PDF

Info

Publication number
CS258203B1
CS258203B1 CS851035A CS103585A CS258203B1 CS 258203 B1 CS258203 B1 CS 258203B1 CS 851035 A CS851035 A CS 851035A CS 103585 A CS103585 A CS 103585A CS 258203 B1 CS258203 B1 CS 258203B1
Authority
CS
Czechoslovakia
Prior art keywords
albumin
solution
adjusted
added
supernatant
Prior art date
Application number
CS851035A
Other languages
Czech (cs)
Slovak (sk)
Other versions
CS103585A1 (en
Inventor
Ivan Mikula
Jan Rosocha
Jozef Bulik
Original Assignee
Ivan Mikula
Jan Rosocha
Jozef Bulik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivan Mikula, Jan Rosocha, Jozef Bulik filed Critical Ivan Mikula
Priority to CS851035A priority Critical patent/CS258203B1/en
Publication of CS103585A1 publication Critical patent/CS103585A1/en
Publication of CS258203B1 publication Critical patent/CS258203B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Riešinie možno použiť v imunologicko-biologickej výrobě veterinárnych liečebných prípravkov. Očelom je zavedenie do výroby novej technologie spósobu izolácie zvieracieho albuminu, pri ktorej je zachovaná nativita bielkoviny a dosahovaná vyššia výtažnosť oproti súčasnému stavu poznania. Uvedený izolačný postup představuje iba jeden operačný stupeň a může byť vykonaný pri izbovej teplote. Zjednodušenie izolačného postupu sa dosahuje tým, že krvná plazma, resp. sérum sa stabilizuje N-acetyl-DL-tryptofánom a Na-kaprylátom, pH sa upraví na hodnotu 6,0 až 6,1 a přidá sa 96 % etanol v množstve 12 až 18 objemových percent. Nasledujúcim zahriatím roztoku pri 45 až 55 °C a úpravou hodnoty pH na 5,0 až 5,1 vzniklý precipitát sa odstráni a supernatant představuje albumin minimálně o 95 % elektroforetickej čistotě.The solution can be used in immuno-biological production of veterinary medicinal products. The aim is to introduce a new production Animal albumin isolation technology at which protein nativity is maintained and higher yields compared to current state of knowledge. Said insulating the procedure represents only one operating stage and can be carried out at room temperature. simplification isolation process is achieved by that blood plasma, respectively. the serum stabilizes N-acetyl-DL-tryptophan and Na-caprylate, pH is adjusted to 6.0 to 6.1 and added 96% ethanol in an amount of 12 to 18 vol percent. Subsequent heating of the solution at 45 to 55 ° C and pH adjustment to 5.0 to The precipitate formed is removed and the supernatant is removed represents at least 95% albumin electrophoretic purity.

Description

Vynález sa týká spósobu izolácie zvieracieho albuminu.The invention relates to a process for the isolation of animal albumin.

Doteraz v priemyselnom měřítku zvierací albumin z plazmy alebo séra sa izoloval bud vysolovaním vhodnými solami alebo frakciou organických rozpúšťadiel najma etanolom (Cohn E. J. et al.: J. Amer. Chem. Soc., 68, 459 (1946); Nitschmann H. et al.: Helv. Chim. Acta,To date, on an industrial scale, animal albumin from plasma or serum has been isolated either by salting out with suitable salts or a fraction of organic solvents, in particular ethanol (Cohn EJ et al .: J. Amer. Chem. Soc., 68, 459 (1946); Nitschmann H. et al. Helv Chim Acta

37, 866 (1954)). Nevýhodou uvedených technologických postupov je dlhý technologický cyklus, energetická náročnost a náročné technologické zariadenia. Známe sú tiež tepelno-denaturačné metody izolácie albuminu (Hoch H., Chanutin: Arch. of Biochem. and Biophys., 51, 27, 1954; Lundblad J. I.: Vox sang., 5 122, 1971; Schneider W. et al.: Folia haematol., 104, 116,37, 866 (1954). The disadvantages of the mentioned technological procedures are long technological cycle, energy intensity and demanding technological equipment. Thermal denaturation methods for albumin isolation are also known (Hoch H., Chanutin: Arch. Of Biochem. And Biophys., 51, 27, 1954; Lundblad JI: Vox sang., 5,122, 1971; Schneider W. et al .: Folia haematol.

1977).1977).

Avšak nevýhoda týchto je v tom, že balastné bielkoviny sú denaturované pri vysokých teplotách (+70 °C), čo má nepriaznivý vplyv na nativitu a výtažnosť albuminu. Taktiež izolácia albuminu pri výrobě Plazbionu vychádza zo supernatantu po oddělení imunoglobulínov, využívá taktiež poměrně vysokú denaturačnú teplotu (60 °C) a dlhú dobu denaturácie balastných bielkovín (dve hodiny) a napokon dosahuje poměrně nízku elektroforetickú čistotu (max.However, the disadvantage of these is that the ballast proteins are denatured at high temperatures (+ 70 ° C), which adversely affects the native and yield of albumin. Also, the isolation of albumin in the production of Plazbion is based on the supernatant after separation of immunoglobulins, it also uses a relatively high denaturation temperature (60 ° C) and a long period of denaturation of the ballast proteins (two hours) and finally achieves a relatively low electrophoretic purity (max.

%) a výťažnosť konečného výrobku.%) and the yield of the final product.

Vynález rieši izoláciu albuminu zo zvieracej plazmy, resp. séra jednostupftovým technologickým úkonom, pri ktorom dochádza k denaturácii všetkých plazmatických bielkovín mimo albuminu. Přednost uvedeného postupu oproti doteraz používaným je v tom, že mimo skrátenia výrobného cyklu a nižšej denaturačnej teploty sa dosahuje výťažnosť cca o 30 % vyššia.The invention provides for the isolation of albumin from animal plasma, respectively. sera by a single-step technological procedure in which all plasma proteins except albumin are denatured. The advantage of this process over the hitherto used is that in addition to shortening the production cycle and lower denaturation temperature, the yield is about 30% higher.

Podstata izolácie zvieracieho albuminu spočívá v tom, že ku krvnej plazme, resp. séru sa přidá 0,04 M Na-kaprylátu a 0,04 M N-acetyl-DL-tryptofánu. Po dfikladnej homogenizácii sa hodnota pH upraví 1 M kyselinou octovou na hodnotu 6,0 až 6,1. Za stálého miešania sa po kvapkách přidává 96% etanol do koncentrácie 12 až 18 objemových percent. Potom sa roztok za stálého miešania zahrieva pri teplote 45 až 55 UC po dobu 10 minút. Nato pH zmesi sa upraví na hodnotu 5,0 až 5,1 a schladí na teplotu +18 až +20 °C. Vzniklý preoipitát sa odstředí a supernatant sa filtruje a lyofilizuje.The essence of the isolation of animal albumin is that the blood plasma, respectively. 0.04 M Na-caprylate and 0.04 M N-acetyl-DL-tryptophan are added to the serum. After thorough homogenization, the pH was adjusted to 6.0-6.1 with 1M acetic acid. While stirring, 96% ethanol is added dropwise to a concentration of 12-18% by volume. The solution was stirred with continued heating at 45 to 55 C. In a period of 10 minutes. The pH of the mixture was adjusted to 5.0-5.1 and cooled to +18 to +20 ° C. The resulting pre-precipitate is centrifuged and the supernatant is filtered and lyophilized.

Přiklad č. 1Example no. 1

K 3 800 ml hovSdzej plazmy bol přidaný stabilizátor do výslednéj koncentrácie 0,04 M Na-kaprylátu a 0,04 M N-acetyl-Dl-tryptofánu a pH upravené 1 M kyselinou octovou na pH 6,0.To 3800 ml bovine plasma, a stabilizer was added to a final concentration of 0.04 M Na-caprylate and 0.04 M N-acetyl-D1-tryptophan and adjusted to pH 6.0 with 1 M acetic acid.

K zmesi za stálého miešania bol přidaný 96% etanol v množstve 720 ml a roztok bol zohrievaný pri teplote 45 °C po dobu 10 minút. Potom pH roztoku bolo upravené 1 M kyselinou octovou na hodnotu 5,1 a následné roztok bol schladený na teplotu 18 °C. Vzniklý preoipitát bol separovaný na centrifúge. Supernatant bol filtrovaný a lyofilizovaný. Váha lyofilizovaného produktu 72 g, elektrorofetická čistota 95,8.To the mixture with stirring was added 96% ethanol in an amount of 720 ml and the solution was heated at 45 ° C for 10 minutes. Then the pH of the solution was adjusted to 5.1 with 1M acetic acid and the subsequent solution was cooled to 18 ° C. The resulting pre-precipitate was separated on a centrifuge. The supernatant was filtered and lyophilized. Weight of lyophilized product 72 g, electrophoretic purity 95.8.

Příklad č. 2Example # 2

K 3 800 ml hovSdzej plazmy bol přidaný stabilizátor do výslednéj koncentrácie 0,04 M Na-kaprylátu a 0,04 M N-acetyl-Dl-tryptofánu a pH upravené 1 M kyselinou octovou na 6,1.To 3800 ml of bovine plasma, a stabilizer was added to a final concentration of 0.04 M Na-caprylate and 0.04 M N-acetyl-D1-tryptophan and the pH adjusted to 6.1 with 1 M acetic acid.

£ zmesi za stálého miešania bol přidaný 96% etanol v množstve 480 ml a roztok bol zohrievaný pri teplote 55 °C po dobu 10 minút. Potom pH roztoku bolo upravené 1M kyselinou octovou na hodnotu 5,1 a následné roztok bol oohladený na teplotu 20 °C. Vzniklý preoipitát bol separovaný na centrifúge. Supernatant bol filtrovaný a lyofilizovaný. Váha lyofilizovaného produktu 68 g, elektroforetioká čistota 96,1.96% Ethanol (480 ml) was added with stirring, and the solution was heated at 55 ° C for 10 minutes. Then the pH of the solution was adjusted to 5.1 with 1M acetic acid and the subsequent solution was cooled to 20 ° C. The resulting pre-precipitate was separated on a centrifuge. The supernatant was filtered and lyophilized. Weight of lyophilized product 68 g, electrophoretic purity 96.1.

Claims (1)

Spůsob izolácie zvieraoieho albuminu, vyznačujúci sa tým, že zvieracia plazma alebo sérum sa stabilizuje 0,04 M Na-kaprylátom a 0,04 M N-acetyl-DL-tryptofánom, upraví sa pH na 6,0 až 6,1, přidává sa 96% etanol do 12 až 18 % objemových, roztok sa zahrieva na teplotu 45 až 55 °C po dobu 10 minút, potom sa upraví pH na hodnotu 5,0 až 5,1, ochladí sa na teplotu +18 až +20 °C, vzniklý precipitát sa odstředí a supernatant sa filtruje a lyofilizuje.Animal albumin isolation method, characterized in that the animal plasma or serum is stabilized with 0.04 M Na-caprylate and 0.04 M N-acetyl-DL-tryptophan, the pH is adjusted to 6.0-6.1, added 96% ethanol to 12-18% by volume, heat the solution at 45-55 ° C for 10 minutes, then adjust the pH to 5.0-5.1, cool to +18 to +20 ° C , the precipitate formed is centrifuged and the supernatant is filtered and lyophilized.
CS851035A 1985-02-14 1985-02-14 Method of animal albumin insulation CS258203B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS851035A CS258203B1 (en) 1985-02-14 1985-02-14 Method of animal albumin insulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS851035A CS258203B1 (en) 1985-02-14 1985-02-14 Method of animal albumin insulation

Publications (2)

Publication Number Publication Date
CS103585A1 CS103585A1 (en) 1987-09-17
CS258203B1 true CS258203B1 (en) 1988-07-15

Family

ID=5343717

Family Applications (1)

Application Number Title Priority Date Filing Date
CS851035A CS258203B1 (en) 1985-02-14 1985-02-14 Method of animal albumin insulation

Country Status (1)

Country Link
CS (1) CS258203B1 (en)

Also Published As

Publication number Publication date
CS103585A1 (en) 1987-09-17

Similar Documents

Publication Publication Date Title
US4228154A (en) Purification of plasma albumin by ion exchange chromatography
DE69019074T2 (en) Process for the fractionation of plasma proteins.
FI60400C (en) FOERFARANDE FOER UTVINNING AV ALBUMIN UR BLODPLASMA
US7879331B2 (en) Ultra-high yield intravenous immune globulin preparation
US9339530B2 (en) Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
NO168449B (en) MEASURING TRANSFORMER IN A HIGH VOLTAGE SWITCH
JPS6267032A (en) Collection of recombined human beta-interferon
EP0315650B1 (en) Purification of recombinant interleukin-1
US4301064A (en) Ubiquitary tissue protein PP8
CA2018511C (en) Process for the preparation of purified albumin solutions
DK148633B (en) PROCEDURE FOR PREPARING THE INSOLABLE GLOBULIN (CIG) IN THE COLD
US4348315A (en) Process in purification and concentration of the factor VIII-complex
Schmid et al. Partial characterization of the sialic acid-free forms of α1-acid glycoprotein from human plasma
CZ303144B6 (en) Process for preparing recombinant human Chorionic Gonadotropin
Poulik et al. Heterogeneity of H chains of myeloma proteins: susceptibility to papain and trypsin
CS258203B1 (en) Method of animal albumin insulation
Liu et al. Optimization of the culture medium for recombinant protein production under the control of the αAmy3 promoter in a rice suspension-cultured cell expression system
US4371462A (en) Method for purification of anterior pituitary hormones
EP0470086B1 (en) Process for the purification of hemin, a novel hemin derivative and a process for its preparation
US4452893A (en) Cell growth medium supplement
Michon Preparation of Orosomucoid (α1-Acid Seromucoid)
EP0359438A1 (en) Pyridazinone manufacture
CZ287035B6 (en) Process for preparing soluble recombinant proteins from bacterial cells
CS269556B1 (en) Method of albumin insulation
Bennich et al. A phosphopeptide isolated from bovine a-casein after tryptic hydrolysis